Bio-Nuclear Services Limited - Accounts to registrar (filleted) - small 18.1

REGISTERED NUMBER: 01584966 (England and Wales)

Unaudited Financial Statements for the Year Ended 30 September 2017

for

Bio-Nuclear Services Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

to

4

DIRECTOR:

Mr S J Anderson

SECRETARY:

Mr S J Anderson

REGISTERED OFFICE:

Marland House

13 Huddersfield Road

Barnsley

South Yorkshire

S70 2LW

REGISTERED NUMBER:

01584966 (England and Wales)

ACCOUNTANTS:

Harris & Co Limited

Chartered Accountants

Marland House

13 Huddersfield Road

Barnsley

South Yorkshire

S70 2LW

FIXED ASSETS

Investments

4

30,901

30,901

CURRENT ASSETS

Cash at bank

41,744

31,961

CREDITORS

Amounts falling due within one year

5

(749

)

(688

)

NET CURRENT ASSETS

40,995

31,273

TOTAL ASSETS LESS CURRENT LIABILITIES

71,896

62,174

CAPITAL AND RESERVES

Called up share capital

6

1,000

1,000

Capital redemption reserve

100

100

Retained earnings

70,796

61,074

SHAREHOLDERS' FUNDS

71,896

62,174

The Company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2017.

The members have not required the Company to obtain an audit of its financial statements for the year ended 30 September 2017 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the Company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the Company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the Company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director on 8 May 2018 and were signed by:

Mr S J Anderson - Director

1.	STATUTORY INFORMATION

Bio-Nuclear Services Limited is a private company, limited by shares , registered in England and

Wales. The company's registered number and registered office address can be found on the Company

Information page.

The presentation and functional currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in compliance with FRS 102, 'The Financial Standard

Applicable in the UK and the Republic of Ireland' and the Companies Act 2006. The financial

statements have been prepared on a going concern basis under the historical cost convention,

modified to include certain items at fair value.

Significant judgements and estimates

The principal accounting policies and significant judgements and estimates applied in the preparation

of these financial statements are set out below. These policies, judgements and estimates have been

consistently applied to all years presented unless otherwise stated.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss

Account, except to the extent that it relates to items recognised in other comprehensive income or

directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been

enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at

the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods

different from those in which they are recognised in financial statements. Deferred tax is measured

using tax rates and laws that have been enacted or substantively enacted by the year end and that are

expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable

that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2016 - 1 ) .

4.	FIXED ASSET INVESTMENTS

Other

investments

£

COST

At 1 October 2016

and 30 September 2017

30,901

NET BOOK VALUE

At 30 September 2017

30,901

At 30 September 2016

30,901

5.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2017

2016

£

£

Other creditors

749

688

6.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2017

2016

value:

£

£

1,000

Ordinary

£1

1,000

1,000